Republicans Open Investigation Into FDA’s Response to Tainted Heparin

A group of Republican congressmen who have repeatedly chided the FDA for its handling of the 2007 Chinese tainted heparin crisis are opening a formal investigation into the issue now that they have a majority in the House. In a letter sent to FDA Commissioner Margaret Hamburg Wednesday, Reps. Fred Upton (R-Mich.), the committee’s chairman, Cliff Stearns (R-Fla.) and Michael Burgess (R-Texas) of the House Energy and Commerce Committee say there is a substantial public interest in solving the case.
Drug Industry Daily